PCOS has a new name, and the internet has a lot of opinions about why.
It's called PMOS now. Polyendocrine metabolic ovarian syndrome. Returning guest Julie Duffy Dillon joins me to break down what changed, what didn't, and what the research actually shows about GLP-1 medications and PCOS beyond weight loss.
In this episode, you'll learn:
Why PCOS was renamed PMOS after more than a decade of research
What the name change does and doesn't change about your care
What the research shows about GLP-1s and PCOS insulin resistance, triglycerides, and androgens
Why insurance mostly covers the wrong dose, and who that leaves behind
What to do when your provider starts talking about your weight again
Podden och tillhörande omslagsbild på den här sidan tillhör
Stephanie Dodier. Innehållet i podden är skapat av Stephanie Dodier och inte av,
eller tillsammans med, Poddtoppen.